Effect of footshock stress on place conditioning produced by Δ9-tetrahydrocannabinol and the fatty acid amide hydrolase (FAAH) inhibitor, URB597, in Sprague-Dawley rats
- PMID: 28803323
- DOI: 10.1007/s00213-017-4714-6
Effect of footshock stress on place conditioning produced by Δ9-tetrahydrocannabinol and the fatty acid amide hydrolase (FAAH) inhibitor, URB597, in Sprague-Dawley rats
Abstract
Rationale: Unlike other drugs of abuse, Δ9-tetrahydrocanabinol (THC) is generally aversive in rodent conditioned place preference models, but little is known about how stress may modify THC affective properties.
Objective: We evaluate the potential of footshock stress to enhance the rewarding effects of THC and the fatty acid amide hydrolase inhibitor, URB597, as it has been shown to enhance their anxiolytic effects.
Materials and methods: The effect of footshock stress 24 h prior to each conditioning trial on the rewarding/aversive effects of THC (1, 0.1, 0.5 mg/kg, ip) and URB597 (0.3 mg/kg, ip) was evaluated in an unbiased place conditioning procedure in rats. Subsequently, the same stressor was given immediately prior to conditioning with THC (1 and 0.1 mg/kg). Locomotor activity was also measured during conditioning.
Results: A dose of 1 mg/kg THC, but not 0.1-0.5 mg/kg, produced a conditioned place aversion (CPA) that was not modified by footshock delivered 24 h prior to conditioning trials; however, footshock delivered immediately prior to conditioning trials prevented that CPA. Lower doses of THC and URB597 produced no place conditioning regardless of footshock conditions. A dose of 1 mg/kg THC produced locomotor suppression during conditioning trials that was prevented by footshock delivered 24 h before and reversed to locomotor activation by footshock delivered immediately before conditioning.
Conclusions: Unlike the effect of footshock on THC- and URB597-induced anxiolytic effects, footshock does not promote THC or URB597-induced reward in a conditioned place preference paradigm. However, footshock stress reverses the sedative effects of 1 mg/kg THC.
Keywords: Fatty acid amide hydrolase (FAAH); Fear conditioning; Place conditioning; Stress; Δ9-tetrahydrocanabinol (THC).
Similar articles
-
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.Neuropharmacology. 2008 Jan;54(1):129-40. doi: 10.1016/j.neuropharm.2007.08.011. Epub 2007 Aug 19. Neuropharmacology. 2008. PMID: 17904589 Free PMC article.
-
Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.Pharmacol Biochem Behav. 2010 Oct;96(4):496-500. doi: 10.1016/j.pbb.2010.07.010. Epub 2010 Jul 17. Pharmacol Biochem Behav. 2010. PMID: 20643159
-
Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.Psychopharmacology (Berl). 2015 May;232(9):1655-65. doi: 10.1007/s00213-014-3798-5. Epub 2014 Nov 15. Psychopharmacology (Berl). 2015. PMID: 25395060
-
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.Psychopharmacology (Berl). 2007 Feb;190(2):135-43. doi: 10.1007/s00213-006-0589-7. Epub 2006 Nov 17. Psychopharmacology (Berl). 2007. PMID: 17111174
-
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Drug Alcohol Depend. 2015 Jan 1;146:7-16. doi: 10.1016/j.drugalcdep.2014.11.015. Epub 2014 Nov 26. Drug Alcohol Depend. 2015. PMID: 25479915 Free PMC article.
Cited by
-
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.Cells. 2022 Oct 17;11(20):3262. doi: 10.3390/cells11203262. Cells. 2022. PMID: 36291128 Free PMC article. Review.
-
The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110183. doi: 10.1016/j.pnpbp.2020.110183. Epub 2020 Nov 20. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33221340 Free PMC article.
-
Elucidating interplay between myrcene and cannabinoid receptor 1 receptors to produce antinociception in mouse models of neuropathic pain.Pain. 2025 Mar 18;166(9):2140-2151. doi: 10.1097/j.pain.0000000000003558. Pain. 2025. PMID: 40839768 Free PMC article.
-
Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice.Eur Neuropsychopharmacol. 2021 Feb;43:38-51. doi: 10.1016/j.euroneuro.2020.11.019. Epub 2020 Dec 15. Eur Neuropsychopharmacol. 2021. PMID: 33334652 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical